Clik here to view.
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive...
Only Targeted Biologic Therapy Approved for Use in Adjuvant and Metastatic HER2-positive Breast Cancer - SOUTH SAN FRANCISCO, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Genentech, Inc. (NYSE-DNA)...
View ArticleClik here to view.
Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of...
[via Landmark Tykerb(R) (Lapatinib) Data Published in the New England Journal of Medicine]:Landmark Tykerbterm(R) (Lapatinib) Data Published in the New England Journal of Medicine Study Authors Also...
View ArticleClik here to view.
Peptide vaccine fights off breast tumors with aid of bacteria-mimicking agents
The following discusses a mechanism to reawaken the patient's immune system towards cancerous cells, which is the normal case in our individuals. While this study is in mice, it is important to pay...
View ArticleClik here to view.
Phase II trial of peptide vaccine in breast cancer patients through the US...
   The immunotherapeutic vaccine, AE37, is being developed by Generex' Antigen Express division in the US. The phase II study will enroll patients who have completed standard therapy for...
View ArticleClik here to view.
Why Her-2 has not been a magic bullet in Breast Cancer
The success of the ABL-kinase inhibitor Gleevec in the treatment of BCR–ABL-driven leukaemiaterm (CML) raised hopes that drugs that target key kinases underlying other cancers, such as members of...
View ArticleClik here to view.
Creating New Life Forms That May Help Eradicate Cancer Affecting Women
NORTH BRUNSWICK, N.J., -- Instead of using the usual cancer-fighting modalities, surgery, chemotherapyterm, or radiation, researchers from a drug development company called Advaxis, have embarked on a...
View ArticleClik here to view.
Mechanisms Involved with Tumor Relapse Identified
Researchers at Virginia Commonwealth University's Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling...
View ArticleClik here to view.
Jefferson researchers boost immune 'killer cells,' increase antibody...
Researchers at the Kimmel Cancer Center at Jefferson in Philadelphia have devised a novel method to expand the number of immune system "natural killer (NK)" cells from blood cells outside the body....
View ArticleClik here to view.
New Adjuvant Treatments for Breast Cancer Prove Cost-
New Adjuvant Treatments for Breast Cancer Prove Cost- Effective                    New adjuvant treatments for breast cancer are cost- effective at improving...
View ArticleClik here to view.
Mayo Clinic - Even Tiny Breast Tumors Can Be Aggressive and May Require...
SAN ANTONIO — Breast tumors that are 1 centimeter in size or smaller — no more than 0.4 inch in length — can still be very aggressive and may require more intensive therapy than is routinely...
View Article
